Chemours [CC] vs Linde plc [LIN] Detailed Stock Comparison

Chemours Co.

NYSE
Loading...

Linde plc

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Chemours Co. wins in 6 metrics, Linde plc wins in 15 metrics, with 0 ties. Linde plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemours Co. Linde plc Better
P/E Ratio (TTM) 67.83 34.73 Linde plc
Price-to-Book Ratio 14.22 6.16 Linde plc
Debt-to-Equity Ratio 1,750.60 70.63 Linde plc
PEG Ratio 10.34 26.03 Chemours Co.
EV/EBITDA 11.44 19.48 Chemours Co.
Profit Margin (TTM) -6.65% 20.30% Linde plc
Operating Margin (TTM) 2.03% 28.17% Linde plc
EBITDA Margin (TTM) 2.03% 28.17% Linde plc
Return on Equity -93.80% 17.82% Linde plc
Return on Assets (TTM) 2.49% 7.17% Linde plc
Free Cash Flow (TTM) $51.00M $5.09B Linde plc
Dividend Yield 1.97% 1.49% Chemours Co.
1-Year Return 118.76% 6.44% Chemours Co.
Price-to-Sales Ratio (TTM) 0.61 6.93 Chemours Co.
Enterprise Value $7.29B $259.94B Linde plc
EV/Revenue Ratio 1.25 7.65 Chemours Co.
Gross Profit Margin (TTM) 11.73% 48.12% Linde plc
Revenue per Share (TTM) $39 $72 Linde plc
Earnings per Share (Diluted) $-2.57 $14.63 Linde plc
Beta (Stock Volatility) 1.40 0.79 Linde plc
Short % of Float 9.66% 1.53% Linde plc

Chemours Co. vs Linde plc Stock Performance Analysis

Loading Price Chart...

CC
LIN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemours Co.-2.75%0.49%-16.94%34.82%74.46%84.57%
Linde plc2.35%-0.06%2.84%1.17%24.05%18.28%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemours Co.118.76%-34.13%-40.41%162.25%6.28%6.28%
Linde plc6.44%38.07%65.97%351.46%393.45%799.17%

Performance & Financial Health Analysis: Chemours Co. vs Linde plc

MetricCCLIN
Market Information
Market Cap i$3.63B$236.47B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i2,330,1771,804,155
90 Day Avg. Volume i3,046,6792,343,675
Last Close$22.61$507.57
52 Week Range$9.20 - $28.67$387.78 - $521.28
% from 52W High-21.14%-2.63%
All-Time High$58.08 (Oct 23, 2017)$521.28 (May 01, 2026)
% from All-Time High-61.07%-2.63%
Growth Metrics
Quarterly Revenue Growth-0.02%0.06%
Quarterly Earnings Growth-0.05%-0.11%
Financial Health
Profit Margin (TTM) i-0.07%0.20%
Operating Margin (TTM) i0.02%0.28%
Return on Equity (TTM) i-0.94%0.18%
Debt to Equity (MRQ) i1,750.6070.63
Cash & Liquidity
Book Value per Share (MRQ)$1.67$82.48
Cash per Share (MRQ)$4.46$10.91
Operating Cash Flow (TTM) i$264.00M$10.35B
Levered Free Cash Flow (TTM) i$21.50M$4.79B
Dividends
Last 12-Month Dividend Yield i1.97%1.49%
Last 12-Month Dividend i$0.36$7.60

Valuation & Enterprise Metrics Analysis: Chemours Co. vs Linde plc

MetricCC (Apr 24, 2026)LIN (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i67.8334.73
Forward P/E i10.3426.03
PEG Ratio i10.3426.03
Price to Sales (TTM) i0.616.93
Price to Book (MRQ) i14.226.16
Market Capitalization
Market Capitalization i$3.63B$236.47B
Enterprise Value i$7.29B$259.94B
Enterprise Value Metrics
Enterprise to Revenue i1.257.65
Enterprise to EBITDA i11.4419.48
Risk & Other Metrics
Beta i1.400.79
Book Value per Share (MRQ) i$1.67$82.48

Financial Statements Comparison: Chemours Co. vs Linde plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCC (2025)LIN (2025)
Revenue/Sales i5.81B33.99B
Cost of Goods Sold i4.91B17.39B
COGS % of Revenue i84.5%51.2%
Gross Profit i902.00M16.60B
Gross Margin i15.5%48.8%
Research & Development i108.00M147.00M
Operating Income (EBIT) i-28.00M9.25B
Operating Margin i-0.5%27.2%
EBITDA i376.00M13.55B
EBITDA Margin i6.5%39.9%
Pre-Tax Income i-277.00M8.90B
Pre-Tax Income % of Revenue i-4.8%26.2%
Income Tax i109.00M1.99B
Income Tax % of Revenue i1.9%5.9%
Net Income (Profit) i-386.00M7.06B
Profit Margin i-6.6%20.8%

Balance Sheet & Liquidity Metrics

MetricCC (2025)LIN (2025)
Cash & Equivalents i670.00M5.06B
Total Current Assets i3.00B13.33B
Total Current Assets % of Revenue i51.7%39.2%
Total Current Liabilities i1.69B15.20B
Total Current Liabilities % of Revenue i29.0%44.7%
Long-Term Debt i4.29B21.50B
Long-Term Debt % of Revenue i73.9%63.3%
Total Shareholders Equity i251.00M39.74B
Retained Earnings i1.22B16.61B
Retained Earnings % of Revenue i21.0%48.9%
Property, Plant & Equipment i8.62B12.84B

Cash Flow Statement Comparison

MetricCC (2025)LIN (2025)
Operating Cash Flow i276.00M10.44B
Operating Cash Flow % of Revenue i4.8%30.7%
Capital Expenditures i-213.00MN/A
Free Cash Flow i51.00M5.09B
FCF Margin i0.9%15.0%
Debt Repayment i-889.00M-2.28B
Common Stock Repurchase i0-4.60B

Short Interest & Institutional Ownership Analysis

MetricCCLIN
Shares Short i10.33M7.08M
Short Ratio i2.852.61
Short % of Float i9.66%1.53%
Shares Outstanding i149.89M463.68M
Float Shares i149.66M461.73M
% Held by Insiders i0.31%0.26%
% Held by Institutions i91.19%87.78%
% Held by Public i8.50%11.96%

Dividend Analysis & Yield Comparison: Chemours Co. vs Linde plc

MetricCCLIN
Last 12-Month Dividend i$0.36$7.60
Last 12-Month Dividend Yield i1.97%1.49%
3-Year Avg Annual Dividend i$0.79$6.08
3-Year Avg Dividend Yield i0.96%0.33%
3-Year Total Dividends i$2.36$18.24
Ex-Dividend DateFeb 27, 2026Mar 11, 2026